News for 'Care Ratings'

How To Save Money Under New Tax Regime

How To Save Money Under New Tax Regime

Rediff.com3 Oct 2025

Most think tax-saving deductions exist only in the old regime. But the New one quietly retains 40+ ways to ease your tax load

Are public sector bank employees becoming more productive?

Are public sector bank employees becoming more productive?

Rediff.com27 Jun 2025

Each employee is generating more business than before -- driven by cost rationalisation, digital adoption, and better resource utilisation -- signalling a stronger foundation for sustainable growth and profitability.

GST cut on drugs, medical devices to help patients

GST cut on drugs, medical devices to help patients

Rediff.com4 Sep 2025

The government's move to cut GST on medicines and medical devices while exempting lifesaving drugs from the levy is a bold step that will bring direct relief to patients and families while significantly reducing financial strain on them, pharmaceuticals and healthcare industry players said on Thursday.

GST and income tax cuts to spark sustained growth

GST and income tax cuts to spark sustained growth

Rediff.com4 Sep 2025

GST Reform 2.0, which trims tax slabs from four to two, signals a push for demand-led growth, and together with recent income tax cuts, sets the stage for sustained economic growth, experts said. The Goods and Services Tax (GST) Council on September 3 approved an overhaul of the indirect tax regime by taxing essentials at 5 per cent and other goods at 18 per cent. A new 40 per cent tax will be applicable on luxury and sin items.

GST 2.0: These will get cheaper from September 22

GST 2.0: These will get cheaper from September 22

Rediff.com4 Sep 2025

Some of the key names include: Maruti, M&M, Ashok Leyland, Britannia, Ultratech, JK Cement, Havells, Voltas, Amber, Metro, Trent, LemonTree, Indian Hotels, Niva Bupa, HDFC Life, IGL, Acme Solar, Suzlon, Swiggy, Delhivery, ICICI Bank, HDFC Bank, Bajaj Finance, Shriram Finance," according to a report by Motilal Oswal Financial Services.

FMCG majors cut prices as firms pass on GST benefit to consumers

FMCG majors cut prices as firms pass on GST benefit to consumers

Rediff.com17 Sep 2025

Several fast-moving consumer goods (FMCG) companies have said that they would pass on the full benefit of goods and services tax (GST) rate cuts to consumers starting September 22. Dairy major Mother Dairy, on Tuesday, announced rate cuts in products spanning its portfolio-- from milkshakes to paneer and jams to frozen products under its Safal brand.

Half CA 2 Review: Relatable Drama

Half CA 2 Review: Relatable Drama

Rediff.com28 Aug 2025

Where Half CA 2 scores is in making the audiences care for the characters to the extent that one holds their breath when the results are declared, Deepa Gahlot notes.

Delhi diagnostic players oppose genetic sample outflow ban

Delhi diagnostic players oppose genetic sample outflow ban

Rediff.com29 Sep 2025

The Delhi government's directive banning sending of genetic samples outside the city for advanced prenatal tests has hit opposition, with diagnostic players in the capital citing operational difficulties in complying with the order. This comes after the Annual Report on Registration of Births and Deaths in Delhi 2024 indicated that the city's sex ratio at birth (SRB) had dropped to 920 girls per 1,000 boys in 2024, down from 922 in 2023.

Will RBI cut interest rate this October?

Will RBI cut interest rate this October?

Rediff.com16 Sep 2024

Reserve Bank of India (RBI) Governor Shaktikanta Das has said the decision on interest rate moderation will be based on long-term inflation trajectory and not monthly data. The Monetary Policy Committee (MPC) headed by the RBI Governor is scheduled to meet between October 7 and 9 and take call on interest rate. The RBI kept the repo rate unchanged at 6.5 per cent for the ninth time in a row amid risks from higher food inflation.

Trump's Tariffs: Why India Needs To Be Strategic

Trump's Tariffs: Why India Needs To Be Strategic

Rediff.com12 Aug 2025

In trade negotiations, as in chess, sometimes you need to accept a temporary disadvantage to secure a better long-term position, points out Sonal Varma, chief economist (India and Asia ex-Japan) at Nomura.

LIC drags new business premiums of life insurers by 5.2 %

LIC drags new business premiums of life insurers by 5.2 %

Rediff.com10 Sep 2025

New business premiums of life insurance companies dropped 5.2 per cent year-on-year (YoY) in August to Rs 30,959 crore, owing to a double-digit decline reported by state-owned Life Insurance Corporation (LIC), data from the Life Insurance Council showed. LIC recorded a 17 per cent YoY fall in new business premiums to Rs 16,023 crore during the month, while private life insurers reported a 12 per cent YoY increase to Rs 14,936 crore.

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.

Dr Ramakanta Panda's Heart Beats For Wildlife Too

Dr Ramakanta Panda's Heart Beats For Wildlife Too

Rediff.com29 Sep 2025

Dr Ramakanta Panda's unique exhibition, titled Heartbeats -- Wildlife, Our Shared Future, features a compelling collection of over 200 photographs centred around the theme of wildlife conservation.

'Bihar, bidis start with B': Congress's GST post triggers row

'Bihar, bidis start with B': Congress's GST post triggers row

Rediff.com5 Sep 2025

Union Minister Nityanand Rai launched a scathing attack on Congress, stating that the party takes "pleasure" in insulting Bihar and its people.

Cancer Fear Vs Facts: What To Know

Cancer Fear Vs Facts: What To Know

Rediff.com7 Nov 2025

'If a parent was diagnosed at 50, the child should start screenings 5 to 10 years earlier (around 35 to 40).' 'Awareness of family history and age of onset helps catch the disease early.'

Should You Invest In Corporate Bonds?

Should You Invest In Corporate Bonds?

Rediff.com10 Jul 2025

Only a limited set of investors should invest directly in corporate bonds.

Apple's New Lineup Will Have You Queueing Up To Buy!

Apple's New Lineup Will Have You Queueing Up To Buy!

Rediff.com10 Sep 2025

Apple's iPhone 17, iPhone Air, AirPods Pro 3, and new Watches set the stage for a smarter future, but it comes at a price.

Is Abhimanyu Mishra The Next Bobby Fischer?

Is Abhimanyu Mishra The Next Bobby Fischer?

Rediff.com12 Sep 2025

'He was like a sponge. He soaked up everything we taught him -- and when it came time to play, he'd squeeze out exactly what was needed on the board during tournaments.'

How Mahindra plans to tackle rare earth magnet shortage

How Mahindra plans to tackle rare earth magnet shortage

Rediff.com3 Aug 2025

Mahindra & Mahindra plans to manage rare earth magnet supplies through alternative sourcing channels for the next nine months and will pursue 'engineering efforts' to address the raw material shortage situation amid growing product portfolio, according to a senior company executive. The imposition of export restrictions by China on key rare earth magnets has resulted in supply chain bottlenecks, impacting the user industries, including the auto and electronics sectors.

Idli Kadai Review: Dhanush Delivers!

Idli Kadai Review: Dhanush Delivers!

Rediff.com2 Oct 2025

'Idli Kadai wears its heart on its sleeve, embracing nostalgia and roots with both hands. Dhanush is in top form as an actor and director here, mining most of the material,' recognises Arjun Menon.

'We Will Remove Modi From Delhi, BJP From Bihar'

'We Will Remove Modi From Delhi, BJP From Bihar'

Rediff.com7 Nov 2025

'Without our support Nitish Kumar wouldn't have become chief minister.' 'After the government was formed we became ministers, but our agenda remained the same: Amit Shah had promised reservation for Nishads.' 'He wouldn't listen, so we went to UP and contested 52 seats in the 2022 elections. He didn't like the idea of rebellion.' 'He saw that this man, coming from Bombay, is very sharp. He's made four MLAs now, tomorrow he'll make 40. A time will come when they will make it 125.' 'They bought our MLAs and ousted us from the government.'

'My God, The Number Of Meetings We Had On GST!'

'My God, The Number Of Meetings We Had On GST!'

Rediff.com22 Sep 2025

'It was like rigorously preparing for a solid, good exam...' 'I don't know what marks I will get, but I felt the rigorous preparation of an exam.' 'You may sweat, but I feel rejuvenated.'

Aus ODIs: Big Calls, Bold Omissions On Cards!

Aus ODIs: Big Calls, Bold Omissions On Cards!

Rediff.com3 Oct 2025

Aus ODIs: Bumrah, Gill workload to be discussed, battle between Jaiswal and Abhishek

India's fate at the Oval: All eyes on Bumrah's fitness

India's fate at the Oval: All eyes on Bumrah's fitness

Rediff.com30 Jul 2025

India's hopes of drawing the series at The Oval may hinge on one question: will Jasprit Bumrah play?

Who Will Make India's Playing XI Vs Oman?

Who Will Make India's Playing XI Vs Oman?

Rediff.com18 Sep 2025

As India gears up to face Oman on Friday, September 19, at the Dubai international stadium, the focus returns to cricket.

How a brain-eating amoeba is claiming lives in Kerala

How a brain-eating amoeba is claiming lives in Kerala

Rediff.com18 Sep 2025

Kerala is facing an outbreak of Primary Amoebic Meningoencephalitis (PAM), a rare and deadly brain infection caused by the 'brain-eating amoeba' Naegleria fowleri. Health officials are working to raise awareness and improve diagnostic capabilities.

Cricket's next big story is unfolding in Europe

Cricket's next big story is unfolding in Europe

Rediff.com10 Jul 2025

Cricket minnows Italy are on the cusp of sealing their first appearance at the Twenty20 World Cup after stunning Scotland in the European qualifying tournament on Wednesday.

Baaghi 4 Review: Mindless Violence

Baaghi 4 Review: Mindless Violence

Rediff.com5 Sep 2025

If it wasn't so violent, there would have been a few unintended laughs in Baaghi 4, but this one has not a shred of humour amidst the nonstop mayhem, observes Deepa Gahlot.

How Your Grievances Can Be Fixed!

How Your Grievances Can Be Fixed!

Rediff.com14 Oct 2025

CPGRAMS -- an online platform available to citizens 24x7 to lodge their grievances to public authorities on service delivery -- has existed for close to two decades. But it has never been this active, points out Tamal Bandyopadhyay.

Will Japan's Iron Lady Deepen India-Japan Ties?

Will Japan's Iron Lady Deepen India-Japan Ties?

Rediff.com15 Oct 2025

As a protege of Shinzo Abe, Takaichi is expected to scale bilateral ties much higher. Trade and investment shall grow. People-to-people contacts shall be scaled up, points out Dr Rajaram Panda.

What Insurance Should You Buy?

What Insurance Should You Buy?

Rediff.com1 Sep 2025

Young investors with a higher risk appetite are better off with a combination of term insurance and equity funds.

White House releases order imposing 25% tariffs on India

White House releases order imposing 25% tariffs on India

Rediff.com1 Aug 2025

The United States announced a 25 per cent tariff on India as the White House released an expansive list of duties that Washington, DC will impose on exports from countries around the world.

Will Nitish Kumar Win Just 25 Seats In Bihar Polls?

Will Nitish Kumar Win Just 25 Seats In Bihar Polls?

Rediff.com11 Sep 2025

'No one can ignore PK's prediction about Nitish Kumar's party.'

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

Mirai Review: Too Conventional

Mirai Review: Too Conventional

Rediff.com12 Sep 2025

Mirai is an ambitious, but lazily timid visual effects overkill that squanders away potential with an undercooked early draft screenplay that needed rework, notes Arjun Menon.

Turbulence In Tokyo: What It Means For India

Turbulence In Tokyo: What It Means For India

Rediff.com12 Sep 2025

Prime Minister Shigeru Ishiba's sudden resignation after only a year in office has thrown Japan into political turmoil, raising doubts about how the country will handle economic and regional challenges, observes Dr Rajaram Panda.

Wholesale price inflation eases to 2.31% in Jan

Wholesale price inflation eases to 2.31% in Jan

Rediff.com14 Feb 2025

Wholesale price inflation moderated to 2.31 per cent in January due to the decline in prices of food items especially vegetables, government data released on Friday showed. The Wholesale Price Index (WPI) based inflation was 2.37 per cent in December 2024. It was 0.33 per cent in January 2024.

India contributes more to global growth than US: RBI guv

India contributes more to global growth than US: RBI guv

Rediff.com6 Aug 2025

"We are contributing about 18 per cent, which is more than the US where the contribution is expected to be much less -- about 11 per cent or something. We are doing very well and we will continue to improve further," RBI governor Sanjay Malhotra said, replying to a question on Trump's recent comments.

'This Is The Golden Age Of Chess In India'

'This Is The Golden Age Of Chess In India'

Rediff.com29 Jul 2025

Former women's World champion Susan Polgar believes Indian chess is riding a wave of success and predicted a bright future for the sport in the country.

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Rediff.com23 Dec 2024

India's healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According to data, key contributors to the record fundraising included Sai Life Sciences (Rs 3,043 crore), IKS Health (Rs 2,498 crore), and Sagility India (Rs 2,107 crore).